You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – StageZero Life Sciences said on Monday it has expanded its five-year licensing deal with Oncore Pharma to add StageZero's BreastSentry and the Prostate Health Index to the drug firm's offering.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.